Sofituzumab is a humanised monoclonal antibody targeting the MUC16 protein, commonly used in the synthetic ADC Sofituzumab vedotin, which can be used to treat ovarian cancer and pancreatic cancer.
Purity:
95%
CAS Number:
[1615692-28-8]
Target:
Mucin
* VAT and and shipping costs not included. Errors and price changes excepted